/TCLIF
TCLIF Stock - Theraclion S.A.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TCLIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.12
52W High$0.59
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $830,000 | $1.82M | $1.24M | $1.48M | $744,000 |
| Gross Profit | $-7,183,000 | $-1,080,385 | $-3,050,477 | $-4,540,000 | $-3,807,000 |
| Gross Margin | -865.4% | -59.3% | -246.9% | -306.5% | -511.7% |
| Operating Income | $-6,960,000 | $-3,154,000 | $-6,307,431 | $-4,534,925 | $-4,286,000 |
| Net Income | $-5,757,000 | $-3,675,005 | $-4,964,383 | $-3,760,000 | $-3,905,000 |
| Net Margin | -693.6% | -201.7% | -401.8% | -253.9% | -524.9% |
| EPS | $-0.12 | $-0.08 | $-0.17 | $-0.17 | $-0.24 |
Company Overview
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TCLIFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.08
Q4 2025
EPS Surprise History
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q4 24
No data
Q1 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2026 | Oct 26, 2026 | — | — | — | — |
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q4 2025 | Oct 29, 2025 | — | $-0.08 | — | — |
Q2 2025 | Apr 29, 2025 | — | — | — | — |
Q1 2025 | Jan 6, 2025 | — | $-0.08 | — | — |
Q4 2024 | Oct 30, 2024 | — | $-0.06 | — | — |
Q4 2024 | Oct 30, 2024 | — | — | — | — |
Q3 2024 | Sep 3, 2024 | — | — | — | — |
Q1 2024 | Mar 27, 2024 | — | $-0.03 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.02 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.06 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.04 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.09 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.04 | — | — |
Q3 2022 | Jul 27, 2022 | — | $-0.09 | — | — |
Q2 2022 | Apr 1, 2022 | — | $-0.09 | — | — |
Q3 2021 | Jul 12, 2021 | — | $-0.09 | — | — |
Q3 2021 | Jul 12, 2021 | — | — | — | — |
Q1 2021 | Mar 22, 2021 | — | $-0.13 | — | — |
Q4 2020 | Dec 11, 2020 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about TCLIF
What is TCLIF's current stock price?
Theraclion S.A. (TCLIF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for TCLIF?
No analyst price targets are currently available for this stock.
What sector is Theraclion S.A. in?
Theraclion S.A. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is TCLIF's market cap?
Theraclion S.A. has a market capitalization of $0.00 billion, making it a small-cap company.
Does TCLIF pay dividends?
No, Theraclion S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACNV
Accelera Innovations, Inc
$0.00
Mkt Cap: $0.0B
AFIB
Acutus Medical, Inc.
$0.00
Mkt Cap: $0.0B
ARDS
Aridis Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
BTAX
Biostax Corp.
$0.00
Mkt Cap: $0.0B
CGHC
Capital Group Holdings, Inc.
$0.00
Mkt Cap: $0.0B
IGNT
Ingen Technologies, Inc.
$0.00
Mkt Cap: $0.0B
KKUR
ChromoCure, Inc.
$0.00
Mkt Cap: $0.0B
SESI
SES Solar Inc.
$0.00
Mkt Cap: $0.0B
SWNM
Southwestern Medical Solutions, Inc.
$0.00
Mkt Cap: $0.0B
WPHM
Winston Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to TCLIF for comparison